Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Plerixafor Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 24MG/1.2ML
  • 1.4.3 Type II
• 1.5 Market by Application
  • 1.5.1 Global Plerixafor Market Share by Application (2014-2025)
  • 1.5.2 Non-Hodgkin's lymphoma (NHL) Patients
  • 1.5.3 Multiple myeloma (MM) Patients
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Plerixafor Market Size
• 2.2 Plerixafor Growth Trends by Regions
  • 2.2.1 Plerixafor Market Size by Regions (2014-2025)
  • 2.2.2 Plerixafor Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Plerixafor Market Size by Manufacturers
  • 3.1.1 Global Plerixafor Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Plerixafor Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Plerixafor Market Concentration Ratio (CR5 and HHI)
• 3.2 Plerixafor Key Players Head office and Area Served
• 3.3 Key Players Plerixafor Product/Solution/Service
• 3.4 Date of Enter into Plerixafor Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Plerixafor Market Size by Type (2014-2019)
• 4.2 Global Plerixafor Market Size by Application (2014-2019)

5 United States

• 5.1 United States Plerixafor Market Size (2014-2019)
• 5.2 Plerixafor Key Players in United States
• 5.3 United States Plerixafor Market Size by Type
• 5.4 United States Plerixafor Market Size by Application

6 Europe

• 6.1 Europe Plerixafor Market Size (2014-2019)
• 6.2 Plerixafor Key Players in Europe
• 6.3 Europe Plerixafor Market Size by Type
• 6.4 Europe Plerixafor Market Size by Application

7 China

• 7.1 China Plerixafor Market Size (2014-2019)
• 7.2 Plerixafor Key Players in China
• 7.3 China Plerixafor Market Size by Type
• 7.4 China Plerixafor Market Size by Application

8 Japan

• 8.1 Japan Plerixafor Market Size (2014-2019)
• 8.2 Plerixafor Key Players in Japan
• 8.3 Japan Plerixafor Market Size by Type
• 8.4 Japan Plerixafor Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Plerixafor Market Size (2014-2019)
• 9.2 Plerixafor Key Players in Southeast Asia
• 9.3 Southeast Asia Plerixafor Market Size by Type
• 9.4 Southeast Asia Plerixafor Market Size by Application

10 India

• 10.1 India Plerixafor Market Size (2014-2019)
• 10.2 Plerixafor Key Players in India
• 10.3 India Plerixafor Market Size by Type
• 10.4 India Plerixafor Market Size by Application

11 Central & South America

• 11.1 Central & South America Plerixafor Market Size (2014-2019)
• 11.2 Plerixafor Key Players in Central & South America
• 11.3 Central & South America Plerixafor Market Size by Type
• 11.4 Central & South America Plerixafor Market Size by Application

12 International Players Profiles

• 12.1 sanofi-aventis
  • 12.1.1 sanofi-aventis Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Plerixafor Introduction
  • 12.1.4 sanofi-aventis Revenue in Plerixafor Business (2014-2019)
  • 12.1.5 sanofi-aventis Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
In 2018, the global Plerixafor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Plerixafor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plerixafor development in United States, Europe and China.

The key players covered in this study
sanofi-aventis
...

Market segment by Type, the product can be split into
24MG/1.2ML
Type II

Market segment by Application, split into
Non-Hodgkin's lymphoma (NHL) Patients
Multiple myeloma (MM) Patients

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Plerixafor status, future forecast, growth opportunity, key market and key players.
To present the Plerixafor development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Plerixafor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.